Addiction Toxicology Resources
This page has been created by the ACMT Addiction Toxicology Committee and contains pertinent resources with this focus. If you are an ACMT Member interested in joining this Committee please fill out this request form.
Quick Links
* Denotes webinars accessible only to ACMT Members
Addiction Toxicology Case Conference
The ACMT/ASAM Addiction Toxicology Case Conference is a monthly webinar series that discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology. This activity is free and open to the public.
National Case Conference *
National Journal Club *
2022
July 2021
This month’s topic is Pepper Spray and Tear Gas Agents. The articles will be reviewed by the University of Virginia Program in Medical Toxicology, led by Program Director Heather Borek.
March 2022
This month’s topic is Opioid Overdose and Naltrexone. The articles will be reviewed by the Washington University School of Medicine Program in Medical Toxicology, led by Dr. Evan Schwarz.
2021
May 2021
This month’s topic is Withdrawal and Recent Modalities. The articles will be reviewed by the Rutgers Medical Toxicology Program, led by Dr. Jeena Jaco.
National Grand Rounds *
2022
October 2022
Cannabis Regulation
February 2022
Gone to Pot? The Complex Relationship between Cannabis, Cannabinoids, and Psychosis
2021
October 2021
NPS Discovery – a five-phase approach to NPS identification, characterization, education, and harm reduction
Practice Statements
2021
Sept. Interpretation of Urine Opiate and Opioid Tests. Read statement.
2020
May. Limiting Harms of Vaping and E-cigarette Use. Read statement.
2019
Nov. Interpretation of Urine for Tetrahydrocannabinol Metabolites. Read statement.
Sept. Buprenorphine Administration in the Emergency Department. Read statement.
Apr. Addressing Pediatric Cannabis Exposure. Read statement.
2016
Feb. Safety Issues Regarding Prescription Fentanyl Products. Read statement.
Position Statements
2022
ACMT Position Statement: Allow Optimal Treatment for Healthcare Professionals with Opioid Use Disorder
Ryan T. Marino, Meghan Spyres, Timothy J. Wiegand… in Journal of Medical Toxicology (2022)
Stolbach, A., Connors, N., Nelson, L. et al. ACMT Position Statement: Interpretation of Urine Opiate and Opioid Tests. J. Med. Toxicol. 18, 176–179 (2022). https://doi.org/10.1007/s13181-021-00864-1
2021
ACMT Position Statement: Limiting Harms of Vaping and E-cigarette Use
Maryann Mazer-Amirshahi, Fiona M. Garlich… in Journal of Medical Toxicology (2021)
2020
ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic
Andrew Stolbach, Maryann Mazer-Amirshahi, Evan S. Schwarz… in Journal of Medical Toxicology (2020)
Public Policy Letters
2022
Oct 13, 2022. CSOO Requests DEA and SAMHSA Grant Continued Telehealth Flexibilities for Buprenorphine for OUD Declared in Response to the Opioid PHE. Read letter.
May 13, 2022. The Mainstreaming Addiction Treatment Act. Read letter.
Apr 12, 2022. CSOO Members on FY23 Appropriations Letter Aimed at Strengthening the Addiction Service Workforce. Read letter.
Mar 31, 2022. CSOO Members Support Legislation to Screen, Assess, and Treat Maternal Mental Health Conditions and SUDs. Read letter.
Feb 14, 2022. CSOO Members Advocate the Federal Parity Act be Fully Extended to Medicare, Medicaid, and TRICARE. Read letter.
2021
Jul 26, 2021. CSOO Urges Biden Administration to Fly Flags at Half-Staff on Overdose Awareness Day. Read letter.
May 27, 2021. Introduction of the Support, Treatment, and Overdose Prevention of (S.T.O.P) Fentanyl Act of 2021. Read letter.
May 3, 2021. Excellence in Recovery Housing Act. Read letter.
April 6, 2021. CSOO Urges Congress to Include Funding for Programs to Strengthen the Addiction Service Workforce in Fiscal Year 2022. Read letter.
2020
May 5, 2020. CSOO Urges Congress to Include Key Initiatives to Support the Mental Health and SUD Treatment Infrastructure in Next COVID-19 Package. Read letter.
I’ll Huff and I’ll Puff…
Jun 22, 2020 | ACMT Visual Pearls, Tox & Medications
By: Kathryn T. Kopec, DO and Blake Bauer, MD
“I have a nagging feeling about this”
Oct 5, 2020 | ACMT Visual Pearls, Emergency Medicine, Tox & Medications
By: Brian Lewis, MD, Gilbert Nelson, DO, Thomas Vu, DO and Bryan Judge, MD, FACMT
Case of a Toxic Tea
Nov 9, 2020 | ACMT Visual Pearls, Emergency Medicine, Tox & MedicationsBy: Nicholas Titelbaum, MD, Vir Singh, MD and Daniel Nogee, MD
ACMT Highlights Tox-in-Ten
Episode 45: Pregnancy and Methamphetamine
Dr. Gillian Beauchamp sits down with Dr. Tricia Wright to discuss risk factors leading to methamphetamine use disorder, associated complications in pregnancy, and management of substance use disorder in pregnant and postpartum patients.
Episode 44: Cannabis Use in Pregnancy
Dr. Gillian Beauchamp sits down with Dr. Tricia Wright to discuss the known and theoretical risks of cannabis use during pregnancy and lactation.
Episode 43: Substance Use, Pregnancy, and Stigma
Dr. Gillian Beauchamp sits down with Dr. Mishka Terplan to discuss discrimination and prejudice in relation to substance use in pregnancy.
Episode 42: Neonatal Abstinence Syndrome
Dr. Gillian Beauchamp sits down with Dr. Lori Devlin to discuss Neonatal Abstinence Syndrome (NAS), Neonatal Opioid Withdrawal Syndrome (NOWS), and the treatment of NOWS.
Episode 41: Physical Dependence vs. Addiction vs. Substance Use Disorder
Dr. Gillian Beauchamp sits down with Dr. Kurt Kleinschmidt to discuss the differences between dependence, addiction, and substance use disorder and how it relates to medication associated treatment (MAT).
Episode 40: Does Science Support the DRE Assessment
Dr. Gillian Beuachamp sits down with Assistant Chief of Police Matthew Myers to discuss the Drug Recognition Evaluation (DRE) and the Drug Influence Evaluation (DRE) assessments.
Episode 28: Methamphetamine in Children
Dr. Gillian Beauchamp sits down with Dr. Ayrn O’Connor to discuss the clinical presentation and treatment of methamphetamine toxicity in children.
Episode 27: Neural Network Connectivity and Methamphetamine
Dr. Gillian Beauchamp sits down with Dr. Milky Kohno, PhD to discuss naltrexone as a treatment strategy for methamphetamine use disorder.
Episode 26: Harm Reduction Strategies
Dr. Gillian Beauchamp sits down with Shaun Hopkins to discuss syringe services programs (SSPs) and overdose prevention sites (OPS).
Episode 24: Complicated Alcohol Withdrawal
Dr. Gillian Beauchamp sits down with Dr. Michael Lynch to discuss refractory ethanol withdrawal and the role of ketamine.
Episode 22: Chronic Effects on the Heart by Methamphetamine and Other Stimulants
Dr. Gillian Beauchamp Sits down with Dr. Stephanie Weiss to discuss the chronic effects of methamphetamine and other stimulants such as cocaine on the heart.
Episode 11: The Great US Cannabis Experiment
Dr. Gillian Beauchamp sits down with Dr. Marilyn Huestis to recap her talk The Great US Cannabis Experiment: Short and Long Term Consequences.
Episode 9: Acute Opioid Toxicity: Naloxone Gone Wrong
Dr. Gillian Beauchamp sits down with Emergency Medicine Physician and Medical Toxicologist Dr. Lewis Nelson to discuss dosing, use and potential pitfalls of naloxone for acute opioid overdose.
Episode 8: Buprenorphine
Dr. Gillian Beauchamp sits down with Emergency Medicine Physician and Dr. Timothy Wiegand for a discussion of the history, benefits and potential complications of buprenorphine therapy for opioid use disorder.
Episode 7: Death by Methadone
Dr. Gillian Beauchamp sits down with Emergency Medicine Physician and Medical Toxicologist Dr. Timothy Wiegand for a discussion on the history of methadone and it’s potential toxicity.
Episode 6: Dead Men Do Tell Tales
Dr. Gillian Beauchamp sits down with Chief Medical Examiner of Connecticut, Dr. James Gill. Listen to their discussion about opioid related deaths.
Episode 5: The Opioid Epidemic and How We Got Here
Dr. Gillian Beauchamp sits down with Emergency Medicine Physician and Medical Toxicologist Dr. Jeanmarie Perrone at the Seminar in Forensic Toxicology.